Evaluating the Effects of VQW-765 vs. Placebo in Performance Anxiety
Study sponsor: Vanda Pharmaceuticals
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-08-02Actual
Enrollment · participants230Actual
Source updated2024-03-20Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.